Bellwether Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Bellwether Advisors, LLC
- $556 Million
- Q2 2025
A detailed history of Bellwether Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bellwether Advisors, LLC holds 37 shares of VRTX stock, worth $13,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 37
-0.0%
Holding current value
$13,855
Previous $17,000
5.88%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,813Shares Held
232MCall Options Held
1.51MPut Options Held
1.09M-
Capital World Investors Los Angeles, CA28.5MShares$10.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$8.98 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.98 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.44 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.41 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $96.1B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...